|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | 尿钠排泄、血压、心血管病与死亡率的关系:社区前瞻性流行病学队列研究显示文摘WHO建议人群钠摄人<2 g/d作为预防心血管病的措施之一,但这一目标在任何国家都没有实现。该建议主要基于短期血压试验的个体水平数据,没有来自随机试验或观察性研究的关于低钠摄入与降低心血管事件的数据。前瞻性城市农村流行病学研究目前正在21个国家进行。该文对其中18个国家的数据进行分析,其中包含了临床结果数据。 | Mente A O'Donnell M Rangarajan S McQueen M Dagenais G Wielgosz A Lear S Ah STL Wei L Diaz R Avezum A Lopez-Jaramillo P Lanas F Mony P Szuba A Iqbal R Yusuf R Mohammadifard N Khatib R Yusoff K Ismail N Gulec S Rosengren A Yusufali A Kruger L Tsolekile LP Chifamba J Dans A Alhabib KF Yeates K Teo K Yusuf S 刘莉 叶鹏 | 2018 | 中华高血压杂志2018,26,12: | 29 |
| 2 | Determinants of the impact of blood pressure variability on neurological outcome after acute ischaemic stroke显示文摘Introduction: Increased blood pressure variability (BPV) is detrimental after acute ischaemic stroke, but the interaction between BPV and neuroimaging factors that directly influence stroke outcome has not been explored. Methods: We retrospectively reviewed inpatients from 2007 to 2014 with acute anterior circulation ischaemic stroke, CT perfusion and angiography at hospital admission, and a modified Rankin Scale (MRS) 30- 365 days after stroke onset. BPV indices included SD, coefficient of variation and successive variation of the systolic blood pressure between 0 and 120 hours after admission. Ordinal logistic regression models were fitted to MRS with predictor variables of BPV indices. Models were further stratified by CT perfusion volumetric measurements, proximal vessel occlusion and collateral score. Results: 110 patients met the inclusion criteria. The likelihood of a 1-point rise in the MRS increased with every 10 mm Hg increase in BPV (OR for the 3 BPV indices ranged from 2.27 to 5.54), which was more pronounced in patients with larger ischaemic core volumes (OR 8.37 to 18.0) and larger hypoperfused volumes (OR 6.02 to 15.4). This association also held true for patients with larger mismatch volume, proximal vessel occlusion and good collateral vessels. Conclusions: These results indicate that increased BPV is associated with worse neurological outcome after stroke, particularly in patients with a large lesion core volume, concurrent viable ischaemic penumbra, proximal vessel occlusion and good collaterals. This subset of patients, who are often not candidates for or fail acute stroke therapies such as intravenous tissue plasminogen activator or endovascular thrombectomy, may benefit from interventions aimed at reducing BPV. | Adam de Havenon Alicia Bennett Gregory J Stoddard Gordon Smith Lee Chung Steve O’Donnell J Scott McNally David Tirschwell Jennifer J Majersik | 2017 | Stroke & Vascular Neurology2017,2,1: | 6 |
| 3 | Risk Factors for Posterior Compared to Anterior Ischemic Stroke: An Observational Study of the Registry of the Canadian Stroke Network显示文摘 | Subramanian G Silva J Silver F L Fang J Kapral M K Oczkowski W Gould L O’donnell M J | 2009 | Neuroepidemiology2009,,1: | 2 |
| 4 | The fatigue limit and its elimination显示文摘 | Miller K J O' Donnell J | 1999 | Fatigue & Fracture of Engineering Materials & Structures1999,22,: | 1 |
| 5 | GM-CSF priming with successive concomitaut therapy with low dose Ara-C for older patients with advanced myelodysplastic(MDS),secondary or refractory myeloid leukemia显示文摘 | Donnell J D Sarcinell F | 1998 | Blood1998,,: | 1 |
| 6 | Association between the LIGT1A1 * 28 allele, bilirubin levels, and coronary heart disease in the Framingham Heart Study显示文摘 | Lin J P O Donnell C J Schwaiger J P | 2006 | Circulation2006,114,14: | 1 |
| 7 | Wideband radar for ballistic missile defense and range-Doppler imaging of satellites 显示文摘 | Camp W W Mayhan J T O' Donnell R M | 2000 | The Lincoln Laboratory Journal2000,12,2: | 1 |
| 8 | Association between the UGTIAI * 28 allele, bilirubin levels, and coronary, heart disease in the Framingham Hear| Study 显示文摘 | Lin JP O'Donnell C J Schwaiger JP | 2006 | Cireulalion2006,114,14: | 1 |
| 9 | An-tithrombotic and thrombolytic therapy for ischemic stroke: An-tithrombotic Therapy and Prevention of Thrombosis, 9th ed: Amer-ican College of Chest Physicians Evidence - Based Clinical Prac-tice Guidelines 显示文摘 | LANSBERG M G O'DONNELL M J KHATRI P | 2012 | Chest2012,141,2: | 1 |
| 10 | Sub- cellular distribution of the foot-and-mouth disease virus 3A protein in cells infected with viruses enco- ding wild-type and bovine-attenuated forms of 3A显示文摘 | O'Donnell V K Paeheco J M Henry T M | 2001 | Virology2001,287,1: | 1 |
| 11 | Acute myeloid leukemia显示文摘 | O′Donnell MR Abboud CN Altman J | 2012 | J Natl Compr Canc Netw2012,10,8: | 1 |
| 12 | Therapeutic microRNA delivery suppresses tumorigenesis in a murine liver cancer model显示文摘 | Kota J Chivukula R R O'Donnell K A | 2009 | Cell2009,137,6: | 1 |
| 13 | Clinical and electrophysiological differences between patients with arrhythmogenic right ventricular dysplasia and right ventricular outflow tract taehycardia显示文摘 | O'Donnell D Cox D Bourke J | 2003 | Eur Heart J2003,24,9: | 1 |
| 14 | Granulocyte-macrophage colony-stimulating factor (GM-CSF) priming with successive concomitant low-dose Ara-C for elderly patients with secondary/refractory acute myeloid leukemia or advanced myelodysplastic syndrome显示文摘 | ROSSI H A O'DONNELL J SARCINELLI F | 2002 | Leukemia2002,16,3: | 1 |
| 15 | The effects of pressure and stage of ensilage on the mechanical properties and effluent production potential of grass silage显示文摘 | O'Donnell C Williams A G Biddlestone A J | 1997 | Grass and Forage Science1997,52,1: | 1 |
| 16 | Detection of pseudodiarrhoea by simple clinical assessment of intestinal transit rate 显示文摘 | O' DONNELL LJ VIRJEE J HEATON KW | 1990 | BMJ1990,300,: | 1 |
| 17 | Therapeutic microRNA Delivery Suppresses Tumorigenesis in a Murine Liver Cancer Model显示文摘 | Kota J Chivukula RR O'Donnell KA | | Cell0,,: | 1 |
| 18 | Posted speed limit: To includ~~ or not to include in operating speed models 显示文摘 | Himes S C Donnel| E T Porter R J | 2013 | Transportation Researeh Part A2013,52,: | 1 |
| 19 | Role of nonstructural proteins 3A and 3B in host range and pathogenicity of foot-and-mouth disease virus显示文摘 | Pacheco J M Henry T M O'Donnell V K | 2003 | JVirol2003,77,24: | 1 |
| 20 | Emerging therapies in the long-term management of hyperuricemia and gout 显示文摘 | Stamp L K O'Donnell J L Chapman P T | 2007 | Intern Med J2007,37,4: | 1 |